Massachusetts General Hospital: Body Dysmorphic Disorders trials

The registry lists 14 Body Dysmorphic Disorders studies with Massachusetts General Hospital as lead sponsor. 0 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 2 1Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)CompletedNCT03673046Not applicableResults posted
• Smartphone-Administered App Treatment for Adults With Body Dysmorphic DisorderCompletedNCT03221738Not applicableResults posted
• Oxytocin Administration in BDD and OCDCompletedNCT02671266Phase 2Results posted
• Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic DisorderCompletedNCT01453439Not applicableResults posted
• D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic DisorderCompletedNCT00842309Early Phase 1Results posted
• Effectiveness of Escitalopram in the Treatment of Body Dysmorphic DisorderCompletedNCT00149799Phase 3Results posted
• Understanding Daily Changes in BDD Risk Using SmartphonesCompletedNCT04254575
• A Virtual Reality Study of Cognitive Biases in Body Dysmorphic DisorderCompletedNCT03773549
• Brain Correlates of Self-Focused ProcessingCompletedNCT02808702Not applicable
• Attentional Bias in Body Dysmorphic DisorderCompletedNCT01398904
• Escitalopram Neuroimaging SupplementCompletedNCT01398865
• Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed ProfessionalsActive, not recruitingNCT01075672Not applicable
• Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic DisorderCompletedNCT01002326Not applicable
• Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic DisorderCompletedNCT00106223Not applicable